glp 1 inhibitor Comparing Ozempic, Wegovy and Other GLP-1 Drugs Adjusting Background Therapy when Initiating
Description
The new study by Eli Lilly looked at 4,726 people with obesity or who were overweight from four different trials
BMJ 2021;372:n71
It can take a lot of time and paperwork, and the insurance company may still decide not to pay for it
10.1016/j.ajpc.2024.100679
69705-5/asset/079012c9-a24f-4391-ba39-2f5d03668f6f/main.assets/gr1_lrg.jpg)
Relative to placebo, the reduction of diastolic BP only reached significance for the treatment of exenatide 10 g/twice daily (1.08 mmHg) [620]
